The efficacy and safety of methylprednisolone in hepatitis B virus-related acute-on-chronic liver failure: a prospective multi-center clinical trial

BACKGROUND: Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is a severe condition with high mortality due to lack of efficient therapy. Until now, the use of methylprednisolone (MP) in HBV-ACLF is still controversial. We aimed to evaluate the efficacy and safety of MP in HBV-ACLF...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Lin, Xue, Ran, Zhu, Yueke, Zhao, Juan, Li, Juan, He, Wei-Ping, Wang, Xiao-Mei, Duan, Zhong-Hui, Ren, Mei-Xin, Liu, Hai-Xia, Xing, Hui-Chun, Meng, Qing-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722342/
https://www.ncbi.nlm.nih.gov/pubmed/33287816
http://dx.doi.org/10.1186/s12916-020-01814-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722342/
https://www.ncbi.nlm.nih.gov/pubmed/33287816
http://dx.doi.org/10.1186/s12916-020-01814-4

Ejemplares similares